{"id":209,"date":"2021-11-29T03:34:49","date_gmt":"2021-11-28T19:34:49","guid":{"rendered":"https:\/\/www.testsealabs-kit.com\/?p=209"},"modified":"2022-04-25T19:44:49","modified_gmt":"2022-04-25T11:44:49","slug":"goldsite-obtains-ce-self-testing-certificate-for-the-sars-cov-2-nasal-antigen-self-test","status":"publish","type":"post","link":"https:\/\/www.testsealabs-kit.com\/lt\/goldsite-obtains-ce-self-testing-certificate-for-the-sars-cov-2-nasal-antigen-self-test\/","title":{"rendered":"Testsealabs COVID-19 antigeno greitasis testas gali veiksmingai apr\u0117pti koronaviruso Omicron (B.1.1529) varianto paderm\u0119"},"content":{"rendered":"

\"\"<\/p>\n

\u0160iuo metu m\u016bs\u0173 \u012fmon\u0117 atlieka i\u0161sam\u0173 palyginim\u0105 ir analiz\u0119, remdamasi GISAID duomen\u0173 baz\u0117je paskelbta Omicron mutavusios paderm\u0117s mutacijos vietos nukleor\u016bg\u0161\u010di\u0173 seka ir m\u016bs\u0173 greituosiuose koronaviruso antigeno greit\u0173j\u0173 test\u0173 produktuose naudojamo specifinio anti-N baltymo antik\u016bno atpa\u017einimo epitopu. Analiz\u0117s rezultatai parod\u0117, kad Omicron mutavusios paderm\u0117s mutacijos vieta netur\u0117jo \u012ftakos m\u016bs\u0173 bendrov\u0117s sukurto, gaminamo ir parduodamo greitojo koronaviruso antigeno aptikimo reagento antigeno nustatymui. M\u016bs\u0173 bendrov\u0117s \"Testsealabs COVID-19\" greitasis antigeno nustatymo testas gali veiksmingai apr\u0117pti nauj\u0105j\u0105 koronaviruso Omicron (B.1.1529) mutavusi\u0105 paderm\u0119.<\/p>\n

\"\"<\/p>\n

Ta\u010diau \u0161iuo metu ne\u012fmanoma gauti pavyzd\u017ei\u0173 patikrai, tod\u0117l reikia atlikti v\u0117lesnius patikros bandymus laboratorijoje. M\u016bs\u0173 bendrov\u0117 patikrino m\u016bs\u0173 bendrov\u0117s sukurto greitojo koronaviruso antigeno testo aptikimo veiksmingum\u0105 naudodama tokius metodus, kaip klinikini\u0173 m\u0117gini\u0173 aptikimas ir analiz\u0117, biologini\u0173 mutacij\u0173 sekos analiz\u0117 ir dirbtinai imituoto mutavusio \u0161tamo m\u0117ginio analiz\u0117.
\nIki \u0161iol buvo \u012fvertinta ir patvirtinta, kad m\u016bs\u0173 \u012fmon\u0117s sukurtas greitasis testas \"Testsealabs COVID-19 Antigen Rapid Test\" gali veiksmingai aptikti \u0161ias mutant\u0173 padermes: Alfa (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Lambda (C.37), Eta (B.1.525), Iota (B.1.526), Mu (B.1.621), Kappa (B.1.617.1), Theta, C.36.3, C .1.2, B.1.1.318, B.1.617.3, Zeta, AV.1, A.23.1, Epsilon ir kiti t\u0119siniai. M\u016bs\u0173 bendrov\u0117 ir toliau seks ir steb\u0117s koronaviruso mutacijas ir laiku reaguos \u012f naujausi\u0105 informacij\u0105, kad u\u017etikrint\u0173, jog bendrov\u0117s gaminami ir parduodami greitieji koronaviruso antigeno aptikimo reagentai gali apimti visas pagrindines mutavusi\u0173 koronavirus\u0173 atmainas ir i\u0161vengti nepavykusio aptikimo. D\u0117kojame u\u017e d\u0117mes\u012f.
\nAteityje m\u016bs\u0173 bendrov\u0117 ir toliau steb\u0117s ir steb\u0117s koronaviruso mutacijas ir laiku pateiks naujausi\u0105 informacij\u0105, kad u\u017etikrint\u0173, jog m\u016bs\u0173 bendrov\u0117s gaminami ir parduodami greitieji koronaviruso antigeno aptikimo reagentai apimt\u0173 visas pagrindines mutavusias koronaviruso atmainas ir b\u016bt\u0173 i\u0161vengta nepavykusi\u0173 aptikim\u0173. d\u0117kojame u\u017e d\u0117mes\u012f.<\/p>","protected":false},"excerpt":{"rendered":"

At present, our company conducts detailed comparison and analysis based on the nucleic acid sequence of the mutation site of the Omicron mutant strain published by the GISAID database and the recognition epitope of the specific anti-N protein antibody used in our Coronavirus antigen rapid test products. The analysis results showed that the mutation site… T\u0119skite Testsealabs COVID-19 antigeno greitasis testas gali veiksmingai apr\u0117pti koronaviruso Omicron (B.1.1529) varianto paderm\u0119<\/span> skaitym\u0105<\/a><\/p>","protected":false},"author":1,"featured_media":706,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"class_list":["post-209","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","entry"],"_links":{"self":[{"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/posts\/209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/comments?post=209"}],"version-history":[{"count":0,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/posts\/209\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/media\/706"}],"wp:attachment":[{"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/media?parent=209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/categories?post=209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.testsealabs-kit.com\/lt\/wp-json\/wp\/v2\/tags?post=209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}